5 ud af 7 var grad 3 dyb venetrombose (DVT), og 2 var grad 1 eller 2.
22 Seven patients (3%) on SUTENT and none on placebo in a phase 3 GIST study experienced venous thromboembolic events; five of the seven were Grade 3 deep venous thrombosis (DVT) and two were Grade 1 or 2.